Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.03
-0.18 (-1.71%)
At close: Aug 19, 2025, 10:56 AM
Nurix Therapeutics Revenue
Nurix Therapeutics reported an annual revenue of $54.55M, reflecting a -29.15% growth. For the quarter ending May 31, 2025, Nurix Therapeutics generated $44.06M in revenue.
Revenue (ttm)
54.55M
Revenue Growth
-29.15%
Price / Sales Ratio
27.21
Revenue / Employee
190.73K
Employees
286
Market Cap
766.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Nov 30, 2024 | 54.55M | -29.15% |
| Nov 30, 2023 | 76.99M | +99.31% |
| Nov 30, 2022 | 38.63M | +29.84% |
| Nov 30, 2021 | 29.75M | +66.95% |
| Nov 30, 2020 | 17.82M | -42.73% |
| Nov 30, 2019 | 31.11M | -16.91% |
| Nov 30, 2018 | 37.45M | n/a |